These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8194717)

  • 1. Immunogenetics of chronic liver diseases.
    Manns MP; Krüger M
    Gastroenterology; 1994 Jun; 106(6):1676-97. PubMed ID: 8194717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics in liver disease.
    Donaldson PT
    Baillieres Clin Gastroenterol; 1996 Sep; 10(3):533-49. PubMed ID: 8905122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.
    Mehal WZ; Lo YM; Wordsworth BP; Neuberger JM; Hubscher SC; Fleming KA; Chapman RW
    Gastroenterology; 1994 Jan; 106(1):160-7. PubMed ID: 8276178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
    Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
    Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis.
    Miyamori H; Kato Y; Kobayashi K; Hattori N
    Digestion; 1983; 26(4):213-7. PubMed ID: 6409699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA A1, B8, DR3 extended haplotypes in autoimmune chronic hepatitis.
    Tait B; Mackay IR; Board P; Coggan M; Emery P; Eckardt G
    Gastroenterology; 1989 Aug; 97(2):479-81. PubMed ID: 2787258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.
    Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R
    Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended major histocompatibility complex haplotypes in type I diabetes mellitus.
    Raum D; Awdeh Z; Yunis EJ; Alper CA; Gabbay KH
    J Clin Invest; 1984 Aug; 74(2):449-54. PubMed ID: 6746903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walter-Reed 5, disseminated Kaposi's sarcoma and in normal controls. The ARC-IVIG Study Group.
    Plum G; Siebel E; Bendick C; Rasokat H; Braun M; Krickeberg H; Mauff G
    Vox Sang; 1990; 59 Suppl 1():15-20. PubMed ID: 2238573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular genetics of autoimmune liver disease.
    Donaldson P; Doherty D; Underhill J; Williams R
    Hepatology; 1994 Jul; 20(1 Pt 1):225-39. PubMed ID: 8020893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies.
    Mackay IR; Tait BD
    Gastroenterology; 1980 Jul; 79(1):95-8. PubMed ID: 7380229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.
    Rich S; O'Neill G; Dalmasso AP; Nerl C; Barbosa J
    Diabetes; 1985 May; 34(5):504-9. PubMed ID: 3987976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical immunogenetics of viral hepatitis C in a Caucasoid population of western Siberia].
    Tolokonskaia NP; Konenkov VI
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):78-80. PubMed ID: 10925885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis.
    Manns MP; Bremm A; Schneider PM; Notghi A; Gerken G; Prager-Eberle M; Stradmann-Bellinghausen B; Meyer zum Büschenfelde KH; Rittner C
    Gastroenterology; 1991 Nov; 101(5):1367-73. PubMed ID: 1936808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IMGT/HLA database.
    Robinson J; Marsh SG
    Methods Mol Biol; 2007; 409():43-60. PubMed ID: 18449991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reactivity to hepatitis B vaccination (HBV) in patients with uremia: association with defined HLA antigen configuration and complement protein allotypes C4A, C4B and B factor (Bf)].
    Stachowski J; Runowski D; Kramer J; Madaliński K; Maciejewski J; Baldamus CA
    Przegl Lek; 1995; 52(9):445-54. PubMed ID: 8834646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Immunogenetics of Autoimmune Cholestasis.
    Trivedi PJ; Hirschfield GM
    Clin Liver Dis; 2016 Feb; 20(1):15-31. PubMed ID: 26593288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular heterogeneity of second and fourth components of complement and their genes in systemic sclerosis and association of HLA alleles A1, B8 and DR3 with limited and DR5 with diffuse systemic sclerosis.
    Venneker GT; van den Hoogen FH; van Meegen M; de Kok-Nazaruk M; Hulsmans RF; Boerbooms AM; de Waal LP; Bos JD; Asghar SS
    Exp Clin Immunogenet; 1998; 15(2):90-9. PubMed ID: 9691203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-onset autoimmune hepatitis is associated with a C4A gene deletion.
    Scully LJ; Toze C; Sengar DP; Goldstein R
    Gastroenterology; 1993 May; 104(5):1478-84. PubMed ID: 8482459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.